Hoʻololi ʻo Glidiab: nā kumukūʻai no nā analogue a me nā waiwai o nā lāʻau lapaʻau

ʻO kahi lāʻau lapaʻau hypoglycemic waha mai ka hui o derivatives o sulfonylurea, kahi ʻokoʻa i nā lāʻau like ʻole e ka neʻe ʻana o kahi hā heterocyclic N-loaʻa me ka mea paʻa endocyclic.

Hoʻopau ka Gliclazide i ke kaʻe o ka glucose i loko o ke koko, e hoʻoikaika ana i ka mea huna o ka insulin i ka β-sela o nā mokupuni o Langerhans. Ke hoʻonui nei i ka pae o ka insulin postprandial a me C-peptide e hoʻomau ma hope o 2 mau makahiki o ka lapaʻau. Hoʻopili i nā hopena i ka metabolism o ka kalaka, ʻo ka gliclazide ka hopena hemovascular.

Ka hopena ma ka huna ʻana i ka insulin

Ma ke ʻano 2 diabetes mellitus, hoʻōla hou ka lāʻau lapaʻau i ka piʻi koke o ka mea huna o ka insulin i ka pane ʻana i ka hoʻokomo o glucose a hoʻonui i ka lua o ka ʻikepili o ka insulin. Hoʻonui ʻia ka hoʻonui nui o ka huna ʻana i ka insulin i ka pane ʻana i ka hoʻoulu ʻana ma muli o ka ʻai kai a me ka hoʻokele glucose.

Ka hōʻemi o Glyclazide i ka hōʻemi o ka moku thrombosis liʻiliʻi, ke hoʻomohala i ka hana e hiki ke alakaʻi i ka hoʻomohala ʻana i ka hoʻopiʻi i ka maʻi diabetes mellitus: hoʻoneʻe ʻāpana o ka pākuʻi platelet a me ka pohihihi a me ka hoʻohaʻemi ʻana i nā mea hoʻohuihui o nā platelet activation (beta-thromboglobulin, thromboxane B2), a me ka hoʻihoʻi hou ʻana o ka hana fibrinolytic. hoʻonui hoʻonui hana o ka plasminogen kiko hana.

ʻO ka kontrol glycemic intensia e pili ana i ka hoʻohana ʻana i ka lāʻau lapaʻau Diabeton® MB (glycosylated hemoglobin (HbA1c) 65 mau makahiki) - 30 mg (1/2 papa) i kēlā me kēia lā.

I ka hihia kūpono, hiki ke hoʻohana ʻia ka lāʻau lapaʻau ma kēia laʻana no ka mālama ʻana i nā lāʻau mālama. Me ka hikiʻole i ka mālama glycemic hiki loa, hiki ke hoʻonui ʻia i ka lā o kēlā me kēia lā ka 60 mg, 90 mg a i ʻole ka 120 mg. Hiki ke hoʻonui ʻia ka piʻi ʻana ma mua o ka 1 mahina o ka lāʻau lapaʻau ma kahi kikoʻi i ʻōlelo ʻia ai. ʻO nā mea ʻē aʻe nā mea maʻi i hōʻemi ʻole ka ʻike koko koko ma hope o nā 2 wiki o ka lapaʻau. I kēlā mau hihia, e hoʻonui ʻia ke hina i nā hebedoma 2 ma hope o ka hoʻomaka ʻana o ka hoʻokele.

ʻO ka dosis kiʻekiʻe loa i ʻōlelo ʻia i kēlā lā i kēia lā he 120 mg.

ʻO 1 papa me kahi kala i hoʻolilo ʻia (MB) 60 mg like me 2 papa me kahi hoʻokuʻu i hoʻoliʻiliʻi 30 mg ʻO ka hiki ʻana o kahi puʻupuʻu ma luna o nā papa he 60 mg e hiki iā ʻoe ke hoʻokaʻawale i ka papa a lawe i kahi maʻi o kēlā me kēia lā he 30 mg (1/2 papa 60 mg), a inā pono 90 mg (1 papa 60 mg a me 1/2 papa 60 mg).

ʻO ka hoʻololi ʻana mai ka lawe i ka papa lāʻau Diabeton® 80 mg i nā papa lāʻau Diabeton® MB me kahi hoʻokuʻu o 60 mg:

1 ka papa lāʻau o ka maʻi Diabeton® 80 mg hiki ke hoʻololi ʻia e 1/2 papa me kahi hoʻokuʻu i hoʻihoʻi ʻia ʻo Diabeton® MB 60 mg. Ke hoʻoneʻe nei i nā maʻi mai Diabeton® 80 mg i Diabeton® MB, ua hōʻike ʻia ka mana glycemic mālama.

ʻO ka hūnā mai ka lawe ʻana i kekahi lāʻau lapaʻau hypoglycemic hou i nā papa lāʻau Diabeton® MB me kahi hoʻokuʻu o 60 mg:

ʻO ka papa lāʻau Diabeton® MB me ka hoʻokuʻu ʻia o 60 mg hiki ke hoʻohana ʻia ma kahi o nā mea maʻi hypoglycemic hou no ka hoʻoponopono waha. Ke lawe nei i nā mea maʻi e loaʻa ana i nā lāʻau lapaʻau hypoglycemic ʻē aʻe no ka hoʻokō waha i ka maʻi Diabeton® MB, pono e noʻonoʻo pono ʻia ko lākou ʻeha a me ka hapalua. Ma ke ʻano he kānāwai, ʻaʻole pono ia he wā hoʻololi. Pono e 30 mg ka maʻa mua a laila titrated ma muli o ke kaʻe o ka glucose o ke koko.

Ke hoʻololi nei ka Diabeton® MB me ka derivatives sulfonylurea me ka hapa hapalua lōʻihi e pale aku ai i ka hypoglycemia i hoʻoulu ʻia e ka hopena hoʻohui o ʻelua mau mea maʻi hypoglycemic, hiki iā ʻoe ke hōʻea e lawe iā lākou i kekahi mau lā. ʻO ka pā ma mua o Diabeton® MB ka 30 mg (1/2 papa 60 mg) a, inā pono, hiki ke hoʻonui ʻia ma ka wā e hiki mai ana, e like me ka mea i hōʻike ʻia ma luna nei.

E hui pū me kekahi lāʻau lapaʻau hypoglycemic

Hiki ke hoʻohana ʻia ka Diabeton® MB i ka hui pū me ka biguanidines, alpha glucosidase inhibitors a i ʻole insulin.

Me ka loaʻa ʻole o ka glycemic control, pono e kuhikuhi ʻia ka lāʻau lapaʻau hou me ka mālama pono olakino.

Nā hui ahonui kūikawā

ʻAʻole koi ʻia ka hoʻoponopono ʻana o ka maʻi no nā maʻi i ʻoi aku ma mua o 65 mau makahiki.

Ua hōʻike ʻia nā haʻawina haukaʻa i ka hoʻoponopono ʻia ʻana o nā maʻi i nā maʻi me ka hōʻemi ʻia ʻana o ka renal moderate ʻole. Kuhi ʻia ka nānā ʻana i nā lapaʻau.

I nā mea maʻi i ka hopena o ka hoʻomohala ʻana i ka hypoglycemia (ʻaʻole i lawa a i ʻole ke kaupaona ʻana, ka hōʻeha a i ʻole ka uku ʻana i ka maʻi endocrine endocrine - pituitary a me adrenal insufficiency, hypothyroidism, hiki ke hoʻopau ʻia o nā corticosteroids ma hope o ka lōʻihi a me / a i nā kau palena kiʻekiʻe, nā maʻi koʻikoʻi o ka ʻōnaehana cardiovascular - maʻi maʻi coronary artery koʻikoʻi, atherosclerosis koʻikoʻi o ka carotid arteries, maʻamau atherosclerosis), ke kuhikuhi ʻia, e hoʻohana i ka palena liʻiliʻi (30 mg) o ka lāʻau Diabeton® MB.

E hoʻokō i ka kontrol glycemic intens i mea e pale ai i nā hoʻopiʻi o ka maʻi maʻi, hiki iā ʻoe ke hoʻonui mālie i ka nui o ka Diabeton® MB i 120 mg i kēlā me kēia lā i ka pāʻai a me ka hana e hoʻokō ai i ka pae kiʻekiʻe o HbA1c. Hoʻomaopopo i ka pilikia o ka hoʻomohalaʻana i ka hypoglycemia. Eia kekahi, ʻo nā lāʻau lapaʻaka hypoglycemic ʻē aʻe, no ka laʻana, metformin, he mea hoʻohuihui alpha-glucosidase, kahi deria a thiazolidinedione, hiki ke hoʻohui i ka lāʻau.

ʻAʻole ʻike nā ʻikepili e pili ana i ka hana pono a me ka palekana o ka lāʻau lapaʻau i nā keiki a me nā ʻōpio i lalo o ka makahiki 18.

Nā ʻōkuhi no ka hoʻohana

ʻO Glyclazide (kahi huaahi sulfonylurea a me kahi mea i loaʻa mai ka sulfamide) ka mea hana nui i ka lāʻau. Hana ia i kahi hana hypoglycemic (hypoglycemic).

Ma lalo o ka hopena o kēia neʻe, ua hoʻokomo ʻia ka hana ʻana o ka insulin i ka pancreas a me ka hana o kahi enzyme glycogen synthetase.

Hoʻopili ka Gliclazide i ka manawa ākea ma waena o ka ʻai a me ka hoʻomaka ʻana o ka hana ikaika o ka pancreas e hana ai i ka insulin, hoʻemi i ka glycemia postprandial (hoʻoli ka pau ma hope o ka ʻai).

Eia ka mea, ke pale aku i ka waiwai i ka hoʻopili ʻia o nā wahi o ke koko (platelet aggregation), e hōʻemi ana i ka hoʻoweliweli ʻana o nā kīʻaha koko i ka hormone-adrenaline a me ka hopena o nā pāakaha atherosclerotic ma nā paia o ka vascular.

ʻO nā mea waiwai e hoʻohui i ka lāʻau lapaʻau ka: lactose (nā waiū waiū), ka thickener (paʻakai o ka magnesium a me ka stearic acid), talc pharmaceutical, cellulose, starch.

Hoʻopaʻa piha ka lāʻau lapaʻau e ka digestive tract, ke nānā nei i ke koko ma hope o 6 mau hola. Hoʻopau ʻia ke kaʻina kina e nā ʻōpū a me nā ʻōpū.

Nā hōʻailona a me nā contraindications

Hoʻolālā ʻia nā lāʻau Glidiab no ka hyperglycemia maʻi o ke ʻano lua (non-insulin-depend-diabetes mellitus) i ka hui pū ʻana me ka hoʻoponopono ʻana i ka papaʻai.

ʻO nā hoʻohalike e hoʻohana ʻia nā:

ʻO ka lāʻau lapaʻau no ka maʻi maʻi Forsig a me nā mea hoʻohālike.

• DKA kūlana (diabetes ketoacidosis),
• maʻi (hyper) o ke ʻano o ka ʻano mua,
• ka manawa o ka hānai ʻana a me ka hānai ʻana i ke keiki,
• pilikia hanalāi ʻole a me ka hana hepatic,
• hōʻemi i loko o nā keʻena koko keʻokeʻo,
• mea koko kiʻekiʻe a me nā glucose (hyperosmolar coma),
• indigestion a me nā hoowaiʻa o ka ʻōpū,
• holomua paʻa.

ʻAʻole i kuhikuhi ʻia ka lāʻau lapaʻau no nā keiki, nā mea maʻi me ka hilinaʻi i ka waiʻona a me nā maʻi maʻi tela.

Ka puka ʻana a me ka helu ʻana

Hoʻokomo ʻia ʻo Glidiab i ka pākuʻi papa o 80 mg mau mea ikaika i loko o kahi pā. Aia i ka pahu i ka 60 mau ʻāpana. Aia kekahi mau papa lōʻihi o ka hana o Glidiab MV.

Hoʻolaha ʻia ka nui o ka maʻi e ke kauka no kēlā me kēia maʻi, e noʻonoʻo ana i ka loli o ka nui o ka glucose i ke koko ma mua o ka ʻai ʻana, a ma hope o ka manawa. ʻO ka maʻamau, hoʻomaka ka lāʻau maʻi me kahi awelika maʻamau o kēlā me kēia lā o 80-160 mg (320 loa).

Kuhi ʻia ka lāʻau lapaʻau e hōʻike ʻia ʻelua i ka lā. Inā makemake ʻia e hoʻonui i ka pona, ka manawa manawa ma waena o nā loli i ka hoʻohana ʻana i ka lāʻau lapaʻau ma lalo o ʻelua pule.

Nā hiʻohiʻona

Makemake ʻia me ka lāʻau lapaʻau ka mālama ʻana i kēlā me kēia lā i nā pae o ke kō, a me ka hoʻopiʻi ʻana i ka pāʻai haʻahaʻa. I ka hihia o ke kipi ʻana i ka meaʻai, hoʻonui ʻia i ke ʻano kino, ʻoluʻolu ke kaumaha, pono ia e hōʻike i ke kauka e pili ana i kēia e hoʻololi i ka hewa o ka lāʻau lapaʻau.

Ke hui pū ʻia me nā mea inu wai inu, ʻike ʻia nā hōʻailona āpau o ka ʻalokino ikaika (ka luaʻi, ʻeha, ka ʻeha a me ka ʻōpū).

ʻO ka emi ʻana o ka hopena o ka hopena e hoʻomālamalama ana i kahi paʻa o ka diuretics a me nā contraceptives.

Hōʻikeʻike i nā hopena ʻaoʻao:

• ka hoʻoluhi nui (hyperhidrosis),
• ka hoʻopaʻapaʻa kuʻuna i nā ʻōpū (cramps),
• lohi wikiwiki naʻau (bradycardia),
• hoʻonui nui momona
• hāliuli maoli
• keokeo, keokeo, palopeka,
• makehewa,
• ʻeha a paʻakikī ka hoʻowalewale ʻana (dyspepsia),
• hoʻoweliweli (ʻōhumu),
• epidermal allergy.

ʻAʻole ʻae ʻia kahi overdose o ka lāʻau lapaʻau! Hiki i ke kohu Hypoglycemic mai ka haʻalele ʻana i nā ʻōlelo lapaʻau.

Ua hana ʻia ka lāʻau lapaʻau ma Rusia e Akrikhin OJSC. ʻO ke kumukūʻai e pili ana i nā rubles 135.

He like hoʻohālikelike o Glidiab e pili ana i ka gliclazide, ua kapa ʻia lākou he mau mea like me nā lāʻau like 'ole. Hoʻololi ʻia nā lāʻau lapaʻau e nā ʻano lāʻau lapaʻau like ʻole ma Rusia a i waho, ʻo ka uku o ka hoʻopiha ʻeke ma mua o 250 mau rubles.

ʻO nā mea like pū e hoʻopili ʻia e Glidiab ma ka Russian Federation: Glyclazide, Glucostabil.

Nā lāʻau lapaʻau i hoʻonui ʻia: Diabeton (Palani), Gliclada (Slovenia), Gluktam (Farani), Diabinaxi Diatika (India), Glioral (Yugoslavia), Diabresid (Italia), Oziklid (ʻĀina).

Eia kekahi, aia nā lāʻau lapaʻau e like me Glidiab i ka hana hypoglycemic, ka mea ikaika e ʻike ai ka glimepiride. Hana ia i nā hana like me gliclazide, hōʻike ʻia no ka hoʻohana ʻana ma ka hyperglycemia maʻi o ke ʻano lua.

ʻAʻohe kūlike nā Contitications no kēlā me nā mea e pili ana iā Glidiab. Hoʻokomo ka hopena o ka ʻaoʻao me ka overdose, inā ʻaʻole ke hōʻemi ʻia ka papa inoa o nā hopena maikaʻi ʻole (bradycardia, drowsiness, dyspepsia, ʻiliʻoki o ka ʻili). Hoʻopuka ʻia ka Therapy me kahi meaʻaiʻai.

ʻO nā mākaʻi antiidiabetic Kelemania:

• Amaril. ʻOihana: Aventis Pharma Deutschland GmbH. Uku - 1280 r,
• Maninil. Hoʻoulu: ʻO Berlin-Chemie AG / Menarini Group. 130 nā rubles.

• ʻO Glibenclamide. Mea hana hana Akrikhin HFK, ALSI Pharma, Antiviral, Bivitech, Biosynthesis. ʻO ke kumu he 200 mau rubles.
• Glimepiride. Hoʻokuʻu ʻia ia e nā ʻoihana Vertex, Pharmstandard-Leksredstva. ʻO ke kumu kūʻai -190 mau rubles.

Aia kekahi poʻe kūlike Czech. ʻO Zentiva Production, ma ke kumu kūʻai o 670 rubles, a me ke ʻano Helene Glyurenorm. Mea Hana: BoehringerIngelheimEllas, ma ke kumu he 450 p.

I ka hihia o nā hana hoʻokō, pono ia e hōʻike i ke kauka e pili ana i ka lāʻau lapaʻau me Glidiab a i kāna nā kikowaena, mai ka wā i koho ʻole ʻia ai ka lālani insulin.

Nā Hōʻike Hoʻololi Glidiab

ʻO ka maʻi diabetes type 2 ʻaʻole ia he huaʻōlelo. Lawe wau i Glidiab no mau makahiki, i mea e kōkua ai i ka mālama ʻana i koʻu kaila koko i lalo o ka kaohi.. ^ E Ha yM. Ma ke kūʻai aku, ʻoiaʻiʻo, ʻoi aku nā mea hana hou o kēia manawa, akā nui ka manawa i ʻoi aku ka uku. Ua ʻemi a maikaʻi loa kaʻu lāʻau.

Ma muli o ka hana hewa ʻana o kekahi o nā maʻi, hoʻomaka ka hilo i loko. ʻO ka hopena, ʻo ka maʻi maʻi i ka maʻi diabetes type 2. Ua kuhikuhi aku ke kauka iā Glutenorm. Ua hōʻoiaʻiʻo au me ka pololei, a manaʻo wau i ka hiki. Akā ʻo ka lāʻau lapaʻau e pono ke inu nui a hoʻomau mau ʻia, akā uku nui ia. Ma ke ʻōlelo, ua hoʻololi iā ia me Glidiab. ʻO ka hopena he like, akā ʻo ke kumukūʻai he ʻekolu mau manawa a emi mai.

Ua loaʻa ke kupuna maʻi i ka maʻi maʻamau no ka manawa lōʻihi. Ua kuhikuhi ʻia ʻo ia i ke Diabeton, aʻu e kūʻai mau ai. No ka manawa hope loa, ʻaʻohe Diabeton i ka lāʻau lapaʻau. Ua ʻōlelo ke kāpena lapaʻau e hoʻololi iā Glidiab. Ua kūʻai kū wau wale i ka pale. Wahi a nā loiloi, e hōʻemi pono ana ka lāʻau lapaʻau i nā pae kō, i nā mea āpau he kūpono ia no ka mālama ʻana.

ʻO nā mea hoʻohālikelike Glidiab

ʻOi aku ka uku ma mua o nā mea hoʻohālike mai 8 mau rubles.

ʻO Gliclazide MV kahi papa papa e hoʻomākaukau ai no ka mālama ʻana i ka maʻi mellitus type 2 i hoʻokumu i ka hana like i loko o kahi waihona o 30 mg. Hoʻonohonoho ʻia no ka ʻai maikaʻi a me ka hoʻomaʻamaʻa. Hoʻopili ke Gliclazide MV i nā mea maʻi me ka maʻi 'āpau 1 (ke hilinaʻi-insulin).

ʻOi aku kahi kumukūʻai iʻoi aku ma mua o 10 mau rubles.

ʻO Akrikhin (Lūkia) ʻo Glidiab kekahi o nā mea e hoʻomaikaʻi maikaʻi loa ana no ka gliclazide. Loaʻa ʻia hoʻi ma nā ʻano papa, akā ʻoi aku ka nui o ke kumu o nā ʻUhane ma ʻaneʻi, pono ia e noʻonoʻo pono ma mua o ka hoʻomaka ʻana o ka mālama ʻana. Hoʻomaopopo ʻia no ka maʻi type 2 me ka maikaʻi ʻole a me ka hana kino.

Ua ʻoi aku ka uku o ka analogue mai ka 168 mau rubles.

Hoʻomākaukau papa papa Lūkini no ka mālama ʻana i ka maʻi maʻi. Mea waiwai koʻikoʻi: gliclazide i loko o kahi waihona o 60 mg no ka pā. Hōʻike ʻia no ka mālama ʻana o nā maʻi maʻi type 2 a no nā kumu prophylactic.

Ua ʻoi aku ka uku o ka analogue mai ka 72 mau rubles.

Mea Hana: ʻAmelika (Russia)
Kuhi puka:

• ʻLelo. 2 mg, 30 pcs., Kumukūʻai mai 191 mau rubles
• ʻLelo. 3 mg, 30 pcs., Kumukūʻai mai 272 mau rubles

Nā kumukūʻai Glimepiride i nā lāʻau kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

ʻO Glimepiride kahi lāʻau lapaʻau home no ka mālamaʻana i nā maʻi maʻi type 2. Loaʻa i ke ʻano o nā papa i loaʻa ai ka waiwai like me ka hana a ka 2 i ka 4 mg no kēlā me kēia papa pā.

ʻOi aku ka mea kūʻai aku ma mua o 9 mau rubles.

Mea Hana: No ka huahua
Kuhi puka:

• ʻLelo. me MV 30 mg, 30 pcs., kumukūʻai mai 128 rubles
• ʻLelo. 3 mg, 30 pcs., Kumukūʻai mai 272 mau rubles

Nā kumukūʻai Diabetalong i nā lāʻau kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

ʻO ka maʻi Diabetalong kahi papa lāʻau papa no ka mālama ʻana i ka maʻi mellitus type 2 e pili ana i ka gliclazide i kahi nui o 30 mg. Hāʻawi ʻia ka lāʻau lapaʻau me ka lawa ʻole o ka hoʻoikaika kino a me ka ʻai. Aia nā contraindications a me nā hopena hopena.

ʻOi like ka analogue mai 73 mau rubles.

Mea Hana: Valenta (Lūkia)
Kuhi puka:

• 5 papa papa, 50 pcs., Kumukūʻai mai 46 mau rubles
• ʻLelo. 3 mg, 30 pcs., Kumukūʻai mai 272 mau rubles

ʻO nā kumukūʻai Glibenclamide i kaʻaina kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

ʻO Glibenclamide kahi lāʻau lapaʻau Lūkini maʻalahi loa no ka mālamaʻana i ka maʻi maʻi me ka mea hana like ʻole i ka hoʻopili ʻana. Hoʻokumu ka dosage i ka makahiki o ke ahonui a me ka paʻakikī o ka mālamaʻana i ka maʻi diabetes.

ʻOi aku kahi kumukūʻai ma mua o 190 rubles.

Mea Hana: Sanofi-Aventis S.p.A. (Italia)
Kuhi puka:

• ʻLelo. 1 mg, 30 pcs., Kumukūʻai mai 309 mau rubles
• ʻLelo. 2 mg, 30 pcs., Kumukūʻai mai 539 mau rubles

He kumukūʻai Amaryl i nā mākeke kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

Hoʻohana ʻia ka Amaryl no ka maʻi maʻamau i ka type 2 ma ke ʻano o nā papa i manaʻo ʻia no ka hoʻohana kūloko. E like me ka waiwai hana, hoʻohana ʻia ka glimepiride i loko o kahi waihona o 1 a 4 mg. Aia nā contraindications a me nā hopena hopena.

ʻOi aku kahi kumukūʻai ma mua o 20 mau rubles.

Mea Hana: Berlin-Chemie / Menarini Pharma (Kelemānia)
Kuhi puka:

• Nā papa ʻaina 5 mg, 120 pcs., Kumukūʻai mai 139 rubles
• ʻLelo. 2 mg, 30 pcs., Kumukūʻai mai 539 mau rubles

Nā kumukūʻai no Maninil 5 i nā hale kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

ʻO kahi papa lāʻau no ka mālama ʻana i ka maʻi mellitus no ka glibenclamide (ma ke ʻano micronized) i loko o kahi waihona ʻo 1.75 mg. Hoʻomaopopo ia no ka hoʻohana ʻana i ka mellitus type 2 (me ka hana ʻole o ka ʻai koʻikoʻi).

ʻOi aku ka uku o ka analogue mai ka 67 mau rubles.

Mea Hana: Canonpharma (Lūkia)
Kuhi puka:

• ʻLelo. 2 mg, 30 pcs., Kumukūʻai mai 186 mau rubles
• ʻLelo. 4 mg, 30 pcs., Kumukūʻai mai 252 mau rubles

ʻO Canon glimepiride kumukūʻai ma nā lāʻau lapaʻau pūnaewele
Nā ʻōkuhi no ka hoʻohana

ʻO Glimepiride Canon kekahi o nā mea pono maikaʻi loa no ka mālama ʻana i nā maʻi diabetes mellitus type 2 e pili ana i ka glimepiride i kahi ʻano like. Ua hoʻohālikelike ʻia no ka hiki ʻole o ka meaʻai a me ka hana kino.

Ua ʻoi aku ka uku o ka analogue mai ka 91 mau rubles.

Mea Hana: Akrikhin (Lūkia)
Kuhi puka:

• ʻLelo. 1 mg, 30 pcs., Kumukūʻai mai 210 mau rubles
• ʻLelo. 2 mg, 30 pcs., Kumukūʻai mai 319 mau rubles

ʻO nā kumukūʻai Diameride i nā lāʻau kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

Canonpharma (Lūkini) ʻO Glimepiride Canon kekahi o nā mea pono maikaʻi loa no ka mālama ʻana i ka maʻi mellitus type type 2 e pili ana i ka glimepiride i kahi ʻano like. Ua hoʻohālikelike ʻia no ka hiki ʻole o ka meaʻai a me ka hana kino.

Ua ʻoi aku ka uku o ka analogue mai ka 183 mau rubles.

Mea Hana: Krka (Slovenia)
Kuhi puka:

• Nā Papa 60 mg, 30 pcs., Kumukūʻai mai 302 mau rubles
• ʻLelo. 2 mg, 30 pcs., Kumukūʻai mai 319 mau rubles

ʻO nā kumukūʻai Gliclada i nā papa kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

Hoʻomākaukau no ka papa ʻaina Slovenian no ka mālama ʻana i ka maʻi maʻamau 2. E like me ka waiwai hana, hoʻohana ʻia ka gliclazide i loko o kahi waihona o 30 a 60 mg i hoʻokahi pākaukau. Aia nā contraindications a me nā hopena paha.

Ua ʻoi aku ka uku o ka analogue mai ka 277 mau rubles.

Mea Hana: Beringer Ingelheim International GmbH (Kelemānia)
Kuhi puka:

• ʻLelo. 30 mg, 60 pcs., Kumukūʻai mai 396 mau rubles
• ʻLelo. 2 mg, 30 pcs., Kumukūʻai mai 319 mau rubles

ʻO nā kumukūʻai Glurenorm i nā lāʻau kūʻai pūnaewele
Nā ʻōkuhi no ka hoʻohana

ʻO Glurenorm kahi papa papa e hoʻomākaukau ai no ka mālama ʻana i ka maʻi mellitus type 2 e pili ana i ka glycidone ma kahi pākē o 30 mg. Contraindicated i ke ʻano type mellitus type 1, lactation, hapai, hina a me nā maʻi o ka ʻōpū. Hiki ke loaʻa ka papa inoa o nā contraindications i nā ʻōlelo kuhikuhi.

Nā kuʻuna i ka hoʻonohonoho ʻana a me nā hōʻike no ka hoʻohana

Ke poʻo inoa	He kumukūʻai ma Rusia	Kumukūʻai ma Ukraine
ʻO Bisogamma Glyclazide	91 ʻōpala	182 UAH
Diabeton MR	--	92 UAH
Diagnizide mr Gliclazide	--	15 UAH
ʻO Glidia MV Gliclazide	--	--
ʻO Glykinorm Gliclazide	--	--
Hoʻolaha ʻia Gliclazide	231 rub	57 UAH
Glyclazide 30 MV-Indar Glyclazide	--	--
Hoʻolaha-Hoʻolima Glyclazide-Health	--	36 UAH
ʻO Glioral Glyclazide	--	--
Hoʻolaha Glaclazide Diagnizide	--	14 UAH
Diazide MV Gliclazide	--	46 UAH
Osliklid Gliclazide	--	68 UAH
Gliclazide Diadeon	--	--
ʻO Glyclazide MV Gliclazide	4 ʻōpala	--

ʻO ka papa inoa ma luna o nā mea hoʻohālikelike lapaʻau, e hōʻike ana He kūlike ʻo Glidiab, kūpono loa ia no ka mea ua like lākou me ka like o nā mea hana a me ke kūleʻa e like me ke kuhikuhi ʻana no ka hoʻohana

Nā kumuhana ma o ka hōʻike ʻana a me ke ʻano o ka hoʻohana ʻana

Ke poʻo inoa	He kumukūʻai ma Rusia	Kumukūʻai ma Ukraine
ʻO Glibenclamide Glibenclamide	30 ʻōpala	7 UAH
Maninyl Glibenclamide	54 ʻōpala	37 UAH
ʻO ka Glibenclamide-Health Glibenclamide	--	12 UAH
Glyurenorm glycidone	94 ʻōpala	43 UAH
Amaril	27 ʻōpala	4 UAH
Glimepiride ʻO Glemaz	--	--
Hoʻolaha ʻia ka inoa momona	--	77 UAH
ʻO Glimepiride Glyride	--	149 UAH
Diapiride Glimepiride	--	23 UAH
Alarahi	--	12 UAH
Hoʻolālā ʻia ʻo Glimax	--	35 UAH
Gimepiride-Lugal glimepiride	--	69 UAH
Clay Glimepiride	--	66 UAH
Glabepiride diabrex	--	142 UAH
Nā glimepiride ʻo Meglimide	--	--
Melpamide Glimepiride	--	84 UAH
ʻO ka glimepiride Perinel	--	--
Hoʻohui	--	--
Kahiʻu	--	--
Gimepiride glimepiride	27 ʻōpala	42 UAH
ʻO Glimepiride-teva glimepiride	--	57 UAH
Gimepiride Canon glimepiride	50 ʻōpala	--
ʻO Glimepiride Pharmstandard glimepiride	--	--
Dimaril glimepiride	--	21 UAH
ʻO Glamepiride diamerid	2 hoʻoheʻe	--

Ka ʻokoʻa like, hiki ke pili pū i ka hōʻike a me ke ʻano o ka noi

Ke poʻo inoa	He kumukūʻai ma Rusia	Kumukūʻai ma Ukraine
Avantomed rosiglitazone, metformin hydrochloride	--	--
Bagometua Metformin	--	30 UAH
He metformin Glucofage	12 ʻōpala	15 UAH
Huʻi ʻia ka metformin xr	--	50 UAH
ʻO Reduxin Met Metinin, ʻo Sibutramine	20 ʻōpala	--
Dianormet	--	19 UAH
Metformin Diaformin	--	5 UAH
ʻO ke metformin metformin	13 ʻōpala	12 UAH
Metformin metozin metformin	--	13 UAH
Siofor	208 ʻōpala	27 UAH
ʻO ka metformin hydrochloride	--	--
ʻO Emnorm EP Metformin	--	--
Megifort Metformin	--	15 UAH
Metamine Metformin	--	20 UAH
Metamine SR Metformin	--	20 UAH
Metfogamma metformin	256 ʻōpala	17 UAH
ʻO Tefor metformin	--	--
Glycometer	--	--
Glycomet SR	--	--
Kālaiʻa	37 ʻōpala	--
Metformin Canon metformin, ovidone K 90, mauʻa palaoa, crospovidone, magnesium stearate, talc	26 ʻōpala	--
Insuffor metformin hydrochloride	--	25 UAH
Metformin-teva metformin	43 ʻōpala	22 UAH
Diaformin SR metformin	--	18 UAH
Mepharmil Metformin	--	13 UAH
Metformin Metformin	--	--
Amaryl M Limepiride Maikaʻi ʻia, Metformin Hydrochloride	856 ʻōpala	40 UAH
ʻO ka glibenclamide glibomet, metformin	257 ʻōpala	101 UAH
ʻO Glucovans glibenclamide, metformin	34 ʻōpala	8 UAH
Dianorm-m Glyclazide, Metformin	--	115 UAH
Dibizid-m glipizide, metformin	--	30 UAH
Douglimax glimepiride, metformin	--	44 UAH
Duotrol glibenclamide, metformin	--	--
Hoʻolauleʻa	45 kahi	--
Glibofor metformin hydrochloride, glibenclamide	--	16 UAH
Avandamet	--	--
Avandaglim	--	--
ʻO metumin metumin, sitagliptin	9 ʻōpala	1 UAH
Velmetia metformin, sitagliptin	6026 rub	--
Galvus Met vildagliptin, metformin	259 ʻōpala	1195 UAH
ʻO glimepiride Tripride, metformin, pioglitazone	--	83 UAH
Huihui XR metformin, saxagliptin	--	424 UAH
Metformin Comboglyz Prolong, saxagliptin	130 ʻōpala	--
Gentadueto linagliptin, metformin	--	--
ʻO ka metformin Vipdomet, alogliptin	55 ʻ .pū	1750 UAH
Sinjardi empagliflozin, metformin hydrochloride	240 ʻōpala	--
ʻO Voglibose Oxide	--	21 UAH
He pioglitazone Glutazone	--	66 UAH
ʻO Dropia Sanovel pioglitazone	--	--
ʻO Jasonvia sitagliptin	1369 ʻōpala	277 UAH
Galvus vildagliptin	245 ʻōpala	895 UAH
Onglisa saxagliptin	1472 ʻōpala	48 UAH
Nesina alogliptin	--	--
Vipidia alogliptin	350 ʻōpala	1250 UAH
Trazhenta linagliptin	89 ʻōpala	1434 UAH
Lixumia lixisenatide	--	2498 UAH
Guanem guar gum	9950 ʻōpala	24 UAH
Hoʻopau ka Insvada	--	--
Novonorm Repaglinide	30 ʻōpala	90 UAH
Hoʻokomo ʻo Repodiab Repaglinide	--	--
Baeta Exenatide	150 ʻōpala	4600 UAH
Baeta Long Exenatide	10248 ʻōpala	--
Viktoza liraglutide	8823 kahaki	2900 UAH
Saxenda liraglutide	1374 ʻōpala	13773 UAH
Forksiga Dapagliflozin	--	18 UAH
Forsiga Dapagliflozin	12 ʻōpala	3200 UAH
Invocana canagliflozin	13 ʻōpala	3200 UAH
Jardins Empagliflozin	222 ʻōpala	566 UAH
Trulicity Dulaglutide	115 ʻōpala	--

Pehea e ʻike ai i kahi analogue ʻano maʻalahi o kahi lāʻau lapaʻau nui?

No ka ʻike ʻana i kahi analogue kūʻai like ʻole i ka lāʻau lapaʻau, kahi generic a i ʻole synonymation, ʻo ka mea mua mua mākou i manaʻo no ka hoʻolohe ʻana i ka hoʻopili ʻana, ʻo ia nā ʻano like ʻole o nā mea kaha a me nā hōʻailona no ka hoʻohana. Hōʻike ka mea like ʻole o ka lāʻau lapaʻau me ka lapaʻau a like pū me ka lāʻau lapaʻau, kūloko a me ka mea pono i ʻole nā ​​lāʻau lapaʻau. Eia naʻe, mai poina e pili ana i nā māhele like ʻole o nā lāʻau like like, e hiki ai ke hoʻopilikia i ka palekana a me ka hana. Mai poina e pili ana i nā ʻōlelo aʻo a nā kauka, hiki i ka lāʻau lapaʻau iho ke hōʻino i kou olakino, no laila e ʻōlelo mau i kāu kauka ma mua o ka hoʻohana ʻana i kekahi lāʻau lapaʻau.

Loaʻa ka hopena

Hāʻawi ʻia i kaʻike ma ka gliclazide a me nā derivatives sulfonylurea, pono e noʻonoʻo pono nā hopena hopena.

E like me nā lāʻau lapaʻau sulfonylurea ʻē aʻe, hiki i ka Diabeton® MB ke hōʻeha i ka hypoglycemia i ka hihia ʻole o ka ʻai ʻokoʻa a keu loa ke kāʻī ʻia ka ʻai. ʻO nā ʻōhua kūpono o ka hypoglycemia: ʻeha, ka pōloli nui, ke kaumaha, ka luaʻi, ka nui o ka luhi, ka hoʻomaha moe, ka huhū, ka hoʻomākeʻaka, ka hoʻokaʻawale o ka nānā ʻana, ka lohi ʻana, ke kaumaha, ka pīhoihoi, ka pōʻai a me ka haʻi, ka aphasia, ka haunaele, ka paresis , hōʻeha, nāwaliwali, hoʻopiʻi, bradycardia, delirium, ka hāʻule ʻana o ka hanu, nā puʻuwai, ka nalowale o ka ʻike me ka hoʻomohala hiki i ka coma, a hiki i ka make.

Kahi ʻia nā ʻano o ka Andrenergic: hoʻonui nui ʻia, "clammy" ʻili, hopohopo, tachycardia, hypertension arterial, palpitations, arrhythmia, a me ka angina pectoris.

Ma ke kānāwai, ke hoʻopau ʻia nā hōʻailona o ka hypoglycemia ma ka lawe ʻana i nā palaka (gula). ʻO ka lawe ʻana i nā mea momona ʻaʻole pono. Ke kūʻē nei i kahi kūlana o nā derivatives sulfonylurea, ua hōʻike ʻia nā lūlū o ka hypoglycemia ma hope o kona kūleʻa ʻana i kūleʻa.

Ma ka hypoglycemia koʻikoʻi a lōʻihi paha, ua hōʻike ʻia ka mālama mālama olakino, hiki ke mālama ʻia me ka hoʻokipa, ʻoiai inā he hopena mai ka ʻai paʻakai.

ʻO nā hopena ʻē aʻe

Mai ka pūnaehana ʻana: ʻeha o ka ʻōpū, nausea, ka luaʻi, ka ʻōpū, a me ka constipation. ʻO ka lawe ʻana i ka lāʻau lapaʻau i ka wā o ka ʻaina ʻaina e pale i kēia mau hōʻailona a hōʻalo iki paha iā lākou.

ʻO nā hopena ʻokoʻa hope loa he mea maʻamau.

Ma ka ʻāpana o ka ʻili a me ka kiko subcutaneous: rash, itching, urticaria, erythema, maculopapular rash, bullous rash.

Mai ka pūnaehana hemopoietic: pilikia hematological (anemia, leukopenia, thrombocytopenia, granulocytopenia) ʻaʻole loaʻa. E like me ke kānāwai, he mau hoʻololi kēia mau wali inā ua hoʻokuʻu ʻia ka lāʻau.

Ma ka ʻaoʻao o ka pūpū a me ka pāhau biliary: hoʻonui i ka hana o nā enzyme hepatic (AST, ALT, ka phosphatase alkaline), ma nā kūlana i loaʻa i ka maʻi - hepatitis. Inā hele mai ka laikini cholestatic, pono e hoʻokuʻu ʻia nā lāʻau.

ʻO nā hopena ʻehā aʻe e ʻae ʻia i ka wā ke hoʻokuʻu ʻole ʻia nā lāʻau.

Mai ka ʻaoʻao o ka umauma o ka hihiʻo: hiki ke hele ʻia ka pilikia o ka ʻike transient ma muli o ka loli o ke kaila o ka nui o ke koko, ka mea nui loa i ka hoʻomaka.

ʻO nā hopena ʻaoʻao i loaʻa i ka derivatives sulfonylurea i hōʻike ʻia i nā hihia o ka erythrocytopenia, agranulocytosis, hemolytic anemia, pancytopenia a me allergic vasculitis. Eia kekahi, ʻoiai e lawe ana i nā derivatives sulfonylurea, kahi nui o ka hana ʻana i nā huina o nā huina o ka huina, nā huina pale ʻaia (e like me ka hoʻomohala ʻana o ka cholestasis a me ka jaundice) a me ka hepatitis. Ua emi kēia mau ʻōuli i ka manawa ma hope o ka pau ʻana o ka hoʻomākaukau ʻana o ka sulfonylurea, akā i kekahi mau manawa i alakaʻi ʻia ai ka puʻuwai i make i ke ola.

Nā hopena hopena i hōʻike ʻia i nā hoʻokolohua hoʻāʻo

Ma ka hōʻike ADVANCE, ʻokoʻa iki ka ʻokoʻa o ke ʻano o nā hanana ʻino ʻē aʻe ma waena o nā hui ʻelua o nā maʻi. ʻAʻole loaʻa nā ʻike palekana hou. He helu liʻiliʻi o nā mea maʻi i loaʻa i ka hypoglycemia koʻikoʻi, akā kahi haʻahaʻa ka nui o ka maʻi o ka hypoglycemia. ʻO ka ulu ʻana o ka hypoglycemia i ke koʻikoʻi glycemic control group i ʻoi aku ke kiʻekiʻe ma mua o ka hui glycemic control standard. Kuhi ʻia ka hapa nui o ka hypoglycemia ma ke kaohi o ka mana glycemic control e pili ana i ka mua o ka hoʻomehana ʻo concomitant insulin.

ʻO nā hoʻohālikelike i ka hoʻohana o ka lāʻau DIABETON® MV

• maʻi diabetes type 1
• maʻi maʻamau ketoacidosis, maʻi kanesa, preca maʻi maʻi,
• Hāmeʻa paʻakikī a i ʻole ʻo ka hepatic insufficiency (i kēia mau hihia, ua pono ke hoʻohana i ka insulin),
• con conidance con miconazole,
• hapai
• lactation (umauma),
• makahiki i 18 makahiki
• hypersensitivity i gliclazide a i ʻole o nā mea i loaʻa i ka lāʻau, nā sulfonylureas, sulfonamides.

ʻO ka mea i loaʻa i ka mākaukau he lactose, ʻaʻole i ʻōlelo ʻia ʻo Diabeton® MB no nā mea maʻi me ka intolerance lactose congenital, galactosemia, glucose / galactose malabsorption syndrome.

ʻAʻole ia e hāʻawi i ka lāʻau lapaʻau i ka hui pū me ka phenylbutazone a danazole.

Me ka makaʻala, pono e hoʻohana ʻia ka lāʻau me ka hoʻōla ʻole a / ai ʻole ke kūpaʻa ʻana i ka ʻai, glucose-6-phosphate dehydrogenase, nā maʻi koʻikoʻi o ka ʻōnaehana cardiovascular, hypothyroidism, adrenal a pituitary insufficiency, renal a / a i ʻole hōʻino o ka pilikia, therapy lōʻihi me ka glucocorticosteroids, alkoholism, i nā mea maʻi ma waena. makahiki.

ʻO ka hoʻohanaʻana i ka lāʻau DIABETON® MV i ka wā hāpai a me ka lactation

ʻAʻoheʻike me kahi gliclazide i ka wā hāpai. Hoʻohui ʻia ka ʻikepili ma ka hoʻohana ʻia ʻana o nā kumulā sulfonylurea ma ka hāpai ʻana.

I nā haʻawina ma nā holoholona holoholona, ​​ʻaʻole i ʻike ʻia nā hopena teratogenic o gliclazide.

No ka hōʻemi i ka hopena o ka malenation malenital, pono ka hoʻokele (kūpono pono i ka maʻi maʻi) o ka maʻi mellitus.

ʻAʻole hoʻohana ʻia ka lāʻau hypoglycemic oral i ka wā hāpai. ʻO ka insulin ka lāʻau lapaʻau ke koho pono no ka mālama ʻana i ka maʻi maʻi i nā wahine hāpai. Ke paipai ʻia e pani i ka waiwai o ka lāʻau hypoglycemic waha me ka hoʻōla ʻana o ka insulin i ka wā i hāpai ʻia ai kahi hapaha hoʻolālā, a inā inā loaʻa ka hānau ʻana i ka wā e lawe nei i ka lāʻau.

Ke noʻonoʻo nei i ka hapa ʻole o nā ʻike i ka waiwai o ka gliclazide i ka umauma umauma a me ka hopena o ka hoʻouluʻana i ka hypoglycemia neonatal, ka umauma o ka maʻi o ke kūleʻa ʻana i ka wā o ka lāʻau lapaʻau.

Nā ʻōlelo kikoʻī

Ke kuhikuhi ʻana i ka Diabeton MB, pono e noʻonoʻo e ulu ʻia ka hypoglycemia ma muli o ka lawe ʻana i ka papa o sulfonylurea, a ma kekahi mau manawa i kahi ʻano kaumaha a lōlō, e koi ana i ka hoʻokipa a me ka hoʻokele o dextrose (glucose) i nā lā he nui.

Hiki ke kuhikuhi ʻia ka lāʻau lapaʻau i kēlā mau maʻi nona ka ʻai a maʻa mau i ka ʻaina kakahiaka. He mea nui ia e mālama pono i kahi kōina o nā kōolaʻai me ka meaʻai, e like me hoʻonui ʻia ka hopena o ka hoʻoulu ʻana o ka hypoglycemia me ka liʻiliʻi a ʻole ka hōʻino ʻole o ka ʻai, a me ke kō ʻana o ka ʻai. Hoʻomau pinepine ka hypoglycemia me kahi meaʻai haʻahaʻa-haʻahaʻa, ma hope o ka hoʻolōʻihi ʻana a hoʻoikaika ikaika paha, ma hope o ka inu ʻana i ka wai ʻona, a i ʻole ke lawe ʻana i kekahi mau lāʻau hypoglycemic i ka manawa like.

ʻO ka maʻamau, nalowale nā ​​hōʻailona o ka hypoglycemia ma hope o ka ʻai ʻana i ka ʻai me nā momona i nā haʻaleka (e like me ke kō. Pono e noʻonoʻo i ka lawe ʻana i ka mea momona ʻaʻole e kōkua i ka hoʻopau ʻana i nā hōʻailona hypoglycemic. Hōʻike ka ʻike i ka hoʻohana ʻana i nā derivatives sulfonylurea e hiki ke hele a hypoglycemia ʻoiai ke kōkua maikaʻi loa ʻana o kēia ʻano. Inā hōʻike ʻia nā hōʻailona hypoglycemic a lōʻihi loa paha, ʻoiai me ka hoʻomaʻamaʻa iki ʻana o ka wā ma hope o ka ʻai ʻana i ka ʻai me ka momona, pono ke mālama ʻia ka maʻi olakino.

I mea e pale aku ai i ka hoʻomohala ʻana o ka hypoglycemia, pono ke koho pono ʻia o nā lāʻau lapaʻau a me ke hoʻoponopono regimen, me ka hāʻawi ʻana i ka mea maʻi i ka ʻike holoʻokoʻa e pili ana i ka mālama ʻia.

Hiki i kekahi loli nui o ka hypoglycemia i kēia mau hihia:

• hōʻole a ʻaʻole hiki ʻole i ka mea maʻi (ʻoi aku ka ʻelemakule) e hahai i nā kauoha a ke kauka a nānā i kona kūlana,
• lawa a i ʻole kaʻai ʻana i ka meaʻai pono ʻole, ke kuʻi ʻana i ka pāʻina, ke kaʻina ʻana a me ka loli.
• ka hoʻemi ʻole ʻana ma waena o ka hana pilikino a me ka nui o nā powa i lawe ʻia,
• nā mālamalama maikaʻi ʻole
• uhaiki pohihihi
• ka overdose o ka lāʻau Diabeton® MB,
• kekahi mau pilikia endocrine (maʻi thyroid, pituitary a me adrenal insufficiency)
• ka hana like ʻana o kekahi mau lāʻau lapaʻau.

Loaʻa ka Hepatic / Renal

I nā mea maʻi me ka maʻi hepatic koʻikoʻi a / a i ʻole ka hopena ʻole i kekahi, hiki ke loli i ka pharmacokinetic a me / a i ʻole nā ​​mea huahana i mea kūʻai ʻia o ka gliclazide. Hiki ke lōʻihi ka hypoglycemia i kūkulu i kēia mau maʻi, i kēlā mau hihia, pono e pono ke ʻano kūpono.

ʻO ka ʻike maʻi

Pono e hoʻomaopopo i ka mea maʻi a me nā ʻohana o kona ʻohana e pili ana i ka hopena o ka ulu ʻana o ka hypoglycemia, kāna mau hōʻailona a me nā kūlana i hāpai i kona hoʻomohala ʻana. Pono e ʻike ʻia ka mea maʻi i nā hopena kūpono a me nā pono o ka mālama ʻia i ʻōlelo ʻia. Pono ke kanaka e wehewehe i ka pono o ka meaʻai, ka pono e hoʻomaʻamaʻa maʻamau a me ka mālama pinepine ʻana i nā pae glucose koko.

ʻO ka hakakā glycemic kawalan

ʻO ka hōʻalo ʻana o ka maʻi glycemic i loko o nā mea maʻi e loaʻa ana i ka ʻoihana hypoglycemic ma lalo o kēia mau hihia: maʻi, nā maʻi ʻeha, ka maʻi ʻeha, a me nā hōʻeha nui. I kēia mau kūlana, pono ia e hoʻokaʻawale i ka maʻi me ka Diabeton® MB a kuhikuhi i ka lāʻau lapaʻau.

I nā maʻi he nui, ʻo ka hana o nā mea kūlohelohe hypoglycemic waha, me ka komo pū ʻO ka gliclazide, e lohi i ka wā ma hope o ka mālama lōʻihi. Hiki ke hopena i kēia hopena ma muli o ka hiki ʻana o ka maʻi a me ka hoʻoluhi ʻana i ka pane therapeutic i ka lāʻau. Hōʻike ʻia kēia ʻano maʻi me ke kūpaʻa o ka lāʻau ma waena, pono e hoʻokaʻawale ʻia mai ka mea mua, ʻaʻole hāʻawi ka lāʻau lapaʻau i ka hopena lapaʻau i manaʻo ʻia i ka wā mua. Ma mua o ka hoʻonā ʻana ʻana i ka mea maʻi me ka pale o ka lāʻau lapaʻau kūloko, pono ia e loiloi i ka lawa o ke koho ʻana a me ka hoʻomanawanui ʻana me ka mea ʻai i ka meaʻai i kauoha ʻia.

Ka nānā ʻana o ka lawena ʻana

No ka loiloi i ka mana glycemic, ua hoʻoholo pinepine ʻia ka wikiwiki o ka glucose i ke koko a me ke kiʻekiʻe o ka hemoglobin glycosylated. Eia kekahi, pono e mālama pono pinepine i ka mālama ponoʻī ʻana i nā kaohi glucose koko.

Hiki i nā derivatives Sulfonylurea ke kumu i ka anemia hemolytic i nā mea maʻi me ka nele o ka glucose-6-phosphate. No ka mea, he glivlazide he derony o ka sulfonylurea, pono e mālama pono i ka wā e lawelawe ai i nā mea maʻi me ka glucose-6-phosphate dehydrogenase. Hiki i ka nānā ʻana ke kau ʻana i kahi lāʻau lapaʻau hypoglycemic o kekahi ʻano ʻē aʻe.

Ke keu

I ka hihia o kahi derivatives sulfonylurea, hiki i nā hypoglycemia ke ulu.

Hoʻomaʻomaʻo: inā hele mai nā hōʻailona mody o ka hypoglycemia, pono ʻoe e hoʻonui i ka komo ʻana i nā mea kālaiʻai i ka ʻai, e hoʻemi i ka ʻano o ka lāʻau lapaʻau a / a i ʻole hoʻololi i ka ʻai. E hoʻomau ka mālama pono ʻana i ke ʻano o ka mea maʻi a hiki i ka manawa e hele ai ke kauka i ʻike ʻole ʻia ka ola o ka mea maʻi.

ʻOi paha ka hoʻomohala ʻana i nā kūlana hypoglycemic koʻikoʻi, ka hele pū ʻana me ka coma, kaʻaila a i ʻole nā ​​ʻano neurological ʻē aʻe. Inā ʻike ʻia kēlā mau hōʻailona, ​​pono ka mālama olakino a me ka haukapila koke ʻia.

Inā kānalua a nānā paha i ka hypoglycemic coma, ʻike ʻia ka mea maʻi i ka intravenously me 50 ml o kahi hopena o 20-30% dextrose (glucose). A laila hoʻoneʻe ʻo iv i kahi hopena o 10% o dextrose (glucose) e hoʻomau i ka paila o ka glucose i ke koko ma luna o 1 g / L. Pono e mālama ʻia ka nānā ʻana me ka liʻiliʻi ma ka manawa he 48. Ma ka wā e hiki mai ana, i ka ʻano o ke kūlana o ka mea maʻi, ka nīnau no ka pono o ka nānā hou ʻana i nā hana koʻikoʻi a ka mea maʻi e hoʻoholo.

ʻAʻole kūleʻa ʻia ʻo Dialysis ma muli o ka hoʻopio ʻana i ka gliclazide i nā protein plasma.

Hoʻohui nūhou

ʻO nā lāʻau lapaʻau e hoʻoikaika i ka hopena o ka Diabeton MB (hoʻonui i ka hopena o ka hypoglycemia)

ʻO nā hui e hoʻohālikelike

ʻO ka hoʻohana me ka miconazole (no ka hoʻohana ʻana i ka systemic a i ka wā e hoʻohana ai i ka gel ma ka mucosa waha) e alakaʻi i ka hopena o ka hopena hypoglycemic of glycazide (hypoglycemia e ulu a hiki i kahi coma).

ʻAʻole i hāʻawi ʻia

Hoʻonui ka Phenylbutazone (no ka hoʻohana ʻana i nā ʻōnaehana) i ka hopena hypoglycemic of the sulfonylurea derivatives, e like me haʻalele iā lākou mai ka kamaʻilio ʻana me ka protein plasma a / a i ʻole ka lohi i kā lākou excretion mai ke kino. ʻOi aku ka maikaʻi e hoʻohana i kekahi lāʻau lapaʻau anti-inflammatory. Inā pono ka phenylbutazone, pono e kuhikuhi ʻia ka mea maʻi e pili ana i ka pono o ka hoʻomohala glycemic. Inā pono, e hoʻoponopono ʻia ke ʻano o ka lāʻau lapaʻau ʻo Diabeton® MB ʻoiai e lawe ana i ka phenylbutazone ma hope o ia.

Me ka hoʻohana like pū me ka lāʻau Diabeton® MB, hoʻonaninani ka ethanol i ka hypoglycemia, ke kāohi nei i nā ʻano koina compensatory, a hiki ke kōkua i ka hoʻomohala ʻana o ka comog hypoglycemic. Pono e hōʻole i ka lawe i nā lāʻau lapaʻau, ʻo ia hoʻi ka ethanol, a me ka inu inu inu.

Nā kiaʻi kūikawā

ʻO Gliclazide i hui pū me kekahi mau lāʻau lapaʻau (no ka laʻana, nā kumuhana hou hypoglycemic - insulin, acarbose, biguanides, beta-blockers, fluconazole, ACE inhibitors - captopril, enalapril, histamine H2 receptor blockers, MAO inhibitors, sulfanilam) hopena a me ka hopena o ka hypoglycemia.

ʻO nā lāʻau lapaʻau e hoʻonāwaliwali i ka hopena o ka maʻi Diabeton MV (hoʻonui i ke koko glucose)

ʻAʻole i hāʻawi ʻia

Loaʻa iā Danazole ka hopena maʻi maʻi. Inā lawe pono ʻia kēia lāʻau lapaʻau, mālama ʻia ka mea maʻi e mālama glycemic control. Inā pono e lawe pū i ka lāʻau lapaʻau, pono ʻia e koho ʻia kahi pāʻālua o kahi maʻi hypoglycemic ʻelua i ka wā e lawe danazol a ma hope o kona hoʻopau ʻia ʻana.

Nā kiaʻi kūikawā

ʻO ka hui pū ʻana o ka Diabeton MB me ka chlorpromazine i nā wai kiʻekiʻe (ʻoi aku ma mua o 100 mg / lā) hiki ke alakaʻi i ka piʻi ʻana o ka glucose glucose ma muli o ka emi ʻana o ka huna ʻana i ka insulin. Hoʻomaopopo ʻia ka mālama glycemic control. Inā pono e lawe pū i nā lāʻau lapaʻau, e ʻōlelo ʻia e koho ʻia kahi iki o kahi māpiha hypoglycemic ʻelua i ka wā o ka hoʻokele o ka antipsychotic a ma hope o kona wehe ʻana.

Me ka hana like o GCS (no ka hoʻohana ʻana i ka systemic a me ka hoʻohana / intraarticular, cutaneous, hoʻoponopono administrasi /) hoʻonui i ka ʻike o ka glucose i ke koko me ka hoʻomohala nui o ka ketoacidosis (hoʻemi i ka pānaʻi ʻana i nā pika). Hāʻawi ʻia ka mālama glycemic mālama pono, i ka hoʻomaka ʻana i ka mālama ʻana. Inā pono ʻoe e lawe pū i nā lāʻau lapaʻau, pono paha ʻoe e hoʻoponopono i ka nui o ke ʻano o ka ʻaihue hypoglycemic ʻelua i ka wā o ka hoʻokele ʻana o GCS a ma hope o kā lākou haʻalele.

Me ka hoʻohana pū ʻana o nā agonist beta2-adrenergic (ritodrin, salbutamol, terbutaline) e hoʻonui i ka ʻike o ka glucose i ke koko. Pono ka nānā pono ʻana i ka pono o ka kāohi glycemic pilikino. Inā loaʻa, pono ia e hoʻoneʻe i ka mea maʻi i ka maʻi maʻi insulin.

ʻO nā hui e noʻonoʻo ʻia

Hiki i nā hua o nā sulfonylureas ke hopena i ka hopena o nā anticoagulants i ka wā e hui pū ai. Hiki ke koi ʻia ka hoʻoponopono ʻo Anticoagulant.